Norway extends AstraZeneca vaccine suspension for 3 weeks
Al Jazeera
Norway delays decision on resuming use of AstraZeneca coronavirus vaccine as it investigates several cases of blood clots.
Norway will delay a decision on whether to resume the use of AstraZeneca’s COVID-19 vaccine until April 15, the Norwegian Institute of Public Health (FHI) has said, amid continuing fears over blood clots. Authorities on March 11 suspended the rollout of the vaccine after a small number of younger inoculated people were hospitalised for a combination of blood clots, bleeding and a low count of platelets, some of whom later died. The World Health Organization (WHO) has urged countries to continue using the vaccine and said the benefits outweigh any potential risks. The European Medicines Agency (EMA) has also declared the shot “safe and effective”.
British luxury automaker’s advertising campaign features models of varying ages, genders and races – but no cars.
After Ukraine strikes Russian territory with US missiles, what’s next?
Al Jazeera looks back at the most devastating period in Laos’s history, when the US waged a years-long ‘Secret War’ in the Southeast Asian country.
These were the key developments on the 1,001st day of the Russia-Ukraine war.
Trump allies say they will ‘liberate individuals and businesses from illicit regulations never passed by Congress’.
UN official warns millions of Haitians ‘being held hostage’ amid a surge in gang-related violence in the Haitian capital.
No respite for civilians in Gaza, Lebanon as US blocks UNSC resolution demanding a ceasefire between Israel and Hamas.
Hwang had been convicted in July on 10 criminal charges including wire and securities fraud, market manipulation.
US prosecutors have accused Gautam Adani and others of an elaborate scheme to bribe Indian government officials to secure contracts worth billions of dollars as they sought to raise funds from US investors.
Pool of cable subscribers is shrinking as millions cut the cord and rely on streaming services for their entertainment.